LMH STRATEGIC SOLUTIONS

Lobbying for GLAXOSMITHKLINE LLC · Pharmaceutical Company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.

Pharmacy

Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.